Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Supranormal von Willebrand factor multimers in scleroderma.

P M Mannucci1, R Lombardi, A Lattuada

  • 1Angelo Bianchi Bonomi Hemophilia, University of Milano, Italy.

Blood
|May 1, 1989
PubMed
Summary

Patients with systemic sclerosis often have abnormal von Willebrand factor (vWF) multimers. These supranormal vWF multimers may drive platelet aggregation and contribute to scleroderma pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair.

HSR proceedings in intensive care & cardiovascular anesthesia·2013
Same author

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

Blood·2001
Same author

Grossly abnormal proteolysis of von Willebrand factor (VWF) in a patient heterozygous for a gene deletion and mutation in the dimerization area of VWF.

Thrombosis and haemostasis·2000
Same author

Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis.

Circulation·2000
Same author

Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutation.

British journal of haematology·2000
Same author

Cadaver kidney allocation in the north Italy transplant program on the eve of the new millennium.

Clinical transplants·1999

Area of Science:

  • Hematology
  • Rheumatology
  • Vascular Biology

Background:

  • Platelet activation is crucial in systemic sclerosis pathogenesis.
  • The precise mechanisms linking platelet function to scleroderma remain unclear.

Purpose of the Study:

  • To investigate the presence of supranormal von Willebrand factor (vWF) multimers in patients with systemic sclerosis.
  • To determine if these vWF multimers contribute to platelet aggregation and adhesion in scleroderma.

Main Methods:

  • Plasma samples from 11 systemic sclerosis patients and healthy controls were analyzed.
  • von Willebrand factor (vWF) multimer size distribution was assessed.
  • Effects of low-dose aspirin on vWF multimer levels were evaluated.

Main Results:

Related Experiment Videos

  • Supranormal vWF multimers were detected in all systemic sclerosis patients, irrespective of disease duration or severity.
  • These abnormal vWF multimers were absent in healthy controls.
  • A slight reduction in supranormal vWF multimers was observed after low-dose aspirin administration, suggesting a platelet origin.

Conclusions:

  • Supranormal vWF multimers are a consistent finding in systemic sclerosis.
  • These abnormal multimers likely contribute to scleroderma pathogenesis by promoting platelet aggregation and adhesion.
  • Targeting vWF multimer abnormalities may offer a therapeutic strategy for systemic sclerosis.